title: Coadministration of 5% glucose solution has a decrease in bendamustine-related vascular pain grade.
authors.forename: Toshihisa
authors.initials: T
authors.lastname: Nakashima
authors.forename: Yoshikazu
authors.initials: Y
authors.lastname: Ogawa
authors.forename: Akiko
authors.initials: A
authors.lastname: Kimura
authors.forename: Miki
authors.initials: M
authors.lastname: Kido
authors.forename: Yoshiko
authors.initials: Y
authors.lastname: Okikawa
authors.forename: Takuo
authors.initials: T
authors.lastname: Ito
authors.forename: Atsuko
authors.initials: A
authors.lastname: Hosokawa
authors.forename: Kazuhiro
authors.initials: K
authors.lastname: Kozawa
authors.forename: Hiromasa
authors.initials: H
authors.lastname: Niimi
authors.forename: Takayoshi
authors.initials: T
authors.lastname: Kiba
mesh_terms: D000328:Adult; D000368:Aged; D000069461:Bendamustine Hydrochloride; D005260:Female; D005947:Glucose / Q000008:administration & dosage*; D006801:Humans; D008224:Lymphoma, Follicular / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009588:Nitrogen Mustard Compounds / Q000009:adverse effects* / Q000627:therapeutic use*; D010146:Pain / Q000139:chemically induced* / Q000188:drug therapy*
chemical_list: D009588:Nitrogen Mustard Compounds; D000069461:Bendamustine Hydrochloride; D005947:Glucose